A Prospective Longitudinal Breast Cancer Study

Completed

Conditions studied: Breast Cancer

In brief

The purpose of this study is to obtain sufficient specimens and correlating clinical data from a well-controlled prospective clinical trial collecting longitudinal specimens from subjects diagnosed with any stage of breast cancer.

Key facts

Study ID

NCT02270931

Run by

Fujirebio Diagnostics, Inc.

People needed

130

Starts

2014-05-01

Expected to finish

2021-06-30

Last updated by the study team

2021-08-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males and females, age≥ 18 years
• Histologic/pathologic confirmation of breast cancer
• Any stage of disease: Newly diagnosed, stable, disease progression, surveillance
• Any treatment time point: Treatment naïve, currently receiving or completed therapy for breast cancer including active monitoring.
• Individuals with a history of malignant disease other than breast cancer that was resected greater than 5 years ago and are currently in remission are eligible.
• Able to understand and willing to provide informed consent

You may not qualify if…

• Males and females, age <18 years
• No histologic/pathologic confirmation of breast cancer
• Any concurrent malignancy other than basal or squamous cell skin cancers, in-situ cervical cancer, or breast cancer.
• Treatment plan with fewer than three visits expected in 3 years' time
• Unable to provide informed consent

Where it is running

• Jane Skelton, MD — Boca Raton, Florida, United States
• Broward Health Medical Center — Fort Lauderdale, Florida, United States
• New Hanover Regional Medical Center — Wilmington, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.